74-84 R&C is not a covalent compound but rather a salt or complex formed between L-ascorbic acid (Vitamin C) and the piperazine base 1-((1-phenylcyclohexyl)acetyl)-4-(2-phenylethyl)piperazine, where the piperazine ring is substituted at one nitrogen with a (1-phenylcyclohexyl)acetyl group and at the other with a phenethyl (2-phenylethyl) side chain. The 1-phenylcyclohexyl moiety in its structure is reminiscent of arylcyclohexylamine-type central nervous system (CNS) active agents, though this specific molecule is an acetyl-piperazine derivative rather than a direct phencyclidine analog. The designation "74-84 R&C" likely refers to an internal research code or page range from a proprietary compound registry (possibly from a pharmaceutical company such as Sterling-Winthrop or similar) dating from the 1960s–1980s, when such piperazine derivatives were actively explored for CNS, analgesic, or antihistamine activities. The L-ascorbic acid component serves as a counterion to improve water solubility and potentially enhance stability compared to the free base or hydrochloride salt. Public GHS classification data indicate that this substance is harmful if swallowed (H302). Currently, it appears primarily in chemical supplier catalogs (e.g., BOC Sciences) as a research chemical or standard reference material, with no evidence of widespread commercial pharmaceutical use or approval as a marketed drug.